The role of disposables in rapid response manufacturing : Single-use technologies can be configured and installed fairly quickly, but are they ready to handle the urgency and scale of a pandemic?

BioPharm International

Volumn 22, Issue 8, 2009, Pages 28-31

  Sinclair, Andrew ^a   Monge, Miriam ^a  

^a BioPharm Services UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

BIOTECHNOLOGY; DISPOSABLE EQUIPMENT; DRUG MANUFACTURE; HEALTH CARE INDUSTRY; INFLUENZA A (H1N1); INFORMATION TECHNOLOGY; PANDEMIC; PROCESS DEVELOPMENT; PROCESS TECHNOLOGY; SHORT SURVEY;

EID: 77951643016     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (1)

1. Novartis.com [homepage on the Internet]. Novartis successfully demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine. Available from: www.novartis.com/newsroom/media-releases/en/2009/ 1322241.shtml.